Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population

PURPOSE: Tofacitinib is recommended for treatment of rheumatoid arthritis (RA) in patients with moderate to severe disease activity, but there is not enough evidence on its effectiveness after conventional DMARDs vs its use after biologics. The aim was evaluating the effectiveness of tofacitinib in...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos-Moreno, Pedro, Martinez, Susan, Ibata, Linda, Villarreal, Laura, Rodríguez-Florido, Fernando, Rivero, Manuel, Rojas-Villarraga, Adriana, Galarza-Maldonado, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289171/
https://www.ncbi.nlm.nih.gov/pubmed/35860386
http://dx.doi.org/10.2147/BTT.S361164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289171/
https://www.ncbi.nlm.nih.gov/pubmed/35860386
http://dx.doi.org/10.2147/BTT.S361164

Ejemplares similares